🌟 An update on our exciting progress in learning and predicting the effects of small molecules on the transcriptome! 🌟
transcriptabio.com/post/mastering…
Today, we announced a research collaboration and licensing agreement with @MayoClinic to advance the discovery of new treatments for amyotrophic lateral sclerosis (ALS).
Today we announced results from our research collaboration with @SynfiniInc, which produced a validated-quality lead candidate targeting MSH3, a gene increasingly understood to drive the progression of Huntington’s disease, in just a few weeks.
Characterizing collections of molecules is an important chemoinformatics task. Beyond annotating molecules by common descriptors, can we gain insight by leveraging LLMs for initial triage? Our prototype app, MolSifter, does just that!